Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Pott

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|June 9, 2006
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profilingMichael Hummel, Stefan Bentink, Hilmar Berger, et al.
Plos One|September 15, 2009
A comprehensive microarray-based DNA methylation study of 367 hematological neoplasmsJose I Martin-Subero, Ole Ammerpohl, Marina Bibikova, et al.
Leukemia|June 28, 2019
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation studyMonika Brüggemann, Michaela Kotrová, Henrik Knecht, et al.
Blood Advances|August 23, 2021
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disordersJames Peter Stewart, Jana Gazdova, Nikos Darzentas, et al.
Lancet (London, England)|May 14, 2026
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL NetworkMartin Dreyling, Jeanette Doorduijn, Eva Giné, et al.
Blood Advances|April 16, 2025
Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphomaEvgenii Shumilov, Julia Katharina Scholz, Maximilian Seib, et al.
Cancer Cell|November 16, 2016
Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell LineageAna C Queirós, Renée Beekman, Roser Vilarrasa-Blasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE TrialMarco Ladetto, Katja Gutmair, Rita Tavarozzi, et al.
Blood|December 17, 2008
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profilingJosé I Martín-Subero, Markus Kreuz, Marina Bibikova, et al.
Nature Genetics|November 13, 2012
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencingJulia Richter, Matthias Schlesner, Steve Hoffmann, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|June 9, 2006
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profilingMichael Hummel, Stefan Bentink, Hilmar Berger, et al.
Plos One|September 15, 2009
A comprehensive microarray-based DNA methylation study of 367 hematological neoplasmsJose I Martin-Subero, Ole Ammerpohl, Marina Bibikova, et al.
Leukemia|June 28, 2019
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation studyMonika Brüggemann, Michaela Kotrová, Henrik Knecht, et al.
Blood Advances|August 23, 2021
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disordersJames Peter Stewart, Jana Gazdova, Nikos Darzentas, et al.
Lancet (London, England)|May 14, 2026
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL NetworkMartin Dreyling, Jeanette Doorduijn, Eva Giné, et al.
Blood Advances|April 16, 2025
Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphomaEvgenii Shumilov, Julia Katharina Scholz, Maximilian Seib, et al.
Cancer Cell|November 16, 2016
Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell LineageAna C Queirós, Renée Beekman, Roser Vilarrasa-Blasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE TrialMarco Ladetto, Katja Gutmair, Rita Tavarozzi, et al.
Blood|December 17, 2008
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profilingJosé I Martín-Subero, Markus Kreuz, Marina Bibikova, et al.
Nature Genetics|November 13, 2012
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencingJulia Richter, Matthias Schlesner, Steve Hoffmann, et al.
Pageof 12